Previous evidence indicated that silencing MYC significantly reduced both mRNA and protein levels of PRPS1 in brain tumor-initiating cells, and chromatin immunoprecipitation assay showed that MYC interacted with the promoter regions of PRPS1 gene [41]. The gene discussed is MYC; the disease is brain neoplasm.